Zhejiang Jolly Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of March 2024: 0.03%

Zhejiang Jolly Pharmaceutical Co Ltd (300181) has an Asset Resilience Ratio of 0.03% as of March 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Zhejiang Jolly Pharmaceutical Co Ltd short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CN¥1.00 Million

≈ $146.33K USD Cash + Short-term Investments

Total Assets

CN¥3.86 Billion

≈ $565.52 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2015–2023)

This chart shows how Zhejiang Jolly Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see 300181 total assets.

Liquid Assets Composition Over Time

This chart breaks down Zhejiang Jolly Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore 300181 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥1.00 Million	0.03%
Total Liquid Assets	CN¥1.00 Million	0.03%

Asset Resilience Insights

Limited Liquidity: Zhejiang Jolly Pharmaceutical Co Ltd maintains only 0.03% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Zhejiang Jolly Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Zhejiang Jolly Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Pfizer Inc NYSE:PFE	Drug Manufacturers - General	5.33%
AbbVie Inc NYSE:ABBV	Drug Manufacturers - General	0.02%
Merck & Company Inc NYSE:MRK	Drug Manufacturers - General	0.22%
AstraZeneca PLC MX:AZNN	Drug Manufacturers - General	0.03%
Novartis AG ADR NYSE:NVS	Drug Manufacturers - General	0.06%
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd SHE:300357	Drug Manufacturers - General	9.91%
Firebrick Pharma Ltd AU:FRE	Drug Manufacturers - General	0.29%
Eli Lilly and Company SA:LILY34	Drug Manufacturers - General	6.46%

Annual Asset Resilience Ratio for Zhejiang Jolly Pharmaceutical Co Ltd (2015–2023)

The table below shows the annual Asset Resilience Ratio data for Zhejiang Jolly Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2023-12-31	4.16%	CN¥151.00 Million ≈ $22.10 Million	CN¥3.63 Billion ≈ $530.75 Million	+3.87pp
2022-12-31	0.30%	CN¥10.83 Million ≈ $1.58 Million	CN¥3.64 Billion ≈ $532.52 Million	-2.09pp
2021-12-31	2.38%	CN¥65.52 Million ≈ $9.59 Million	CN¥2.75 Billion ≈ $402.20 Million	-0.09pp
2020-12-31	2.47%	CN¥61.04 Million ≈ $8.93 Million	CN¥2.47 Billion ≈ $361.42 Million	+2.46pp
2019-12-31	0.01%	CN¥300.00K ≈ $43.90K	CN¥2.05 Billion ≈ $300.07 Million	-0.14pp
2018-12-31	0.15%	CN¥3.19 Million ≈ $466.49K	CN¥2.11 Billion ≈ $309.32 Million	-4.77pp
2017-12-31	4.92%	CN¥106.00 Million ≈ $15.51 Million	CN¥2.15 Billion ≈ $314.97 Million	-2.51pp
2016-12-31	7.43%	CN¥151.50 Million ≈ $22.17 Million	CN¥2.04 Billion ≈ $298.20 Million	-4.41pp
2015-12-31	11.84%	CN¥219.13 Million ≈ $32.07 Million	CN¥1.85 Billion ≈ $270.79 Million	--

pp = percentage points

About Zhejiang Jolly Pharmaceutical Co Ltd

SHE:300181 China Drug Manufacturers - General

Market Cap

$1.37 Billion

CN¥9.33 Billion CNY

Market Cap Rank

#7642 Global

#1690 in China

Share Price

CN¥13.30

Change (1 day)

+0.76%

52-Week Range

CN¥12.83 - CN¥19.12

All Time High

CN¥20.53